These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10640768)

  • 21. Complement coating of erythrocytes is reduced following their interaction with neutrophils in vitro without loss of complement receptor 1 (CR1).
    Imrie HJ; Jones DR
    Clin Exp Immunol; 1997 Jul; 109(1):217-22. PubMed ID: 9218847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clearance of anti-double-stranded DNA antibodies: the natural immune complex clearance mechanism.
    Craig ML; Bankovich AJ; McElhenny JL; Taylor RP
    Arthritis Rheum; 2000 Oct; 43(10):2265-75. PubMed ID: 11037886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of model immune complexes to erythrocyte CR1 facilitates immune complex uptake by U937 cells.
    Emlen W; Burdick G; Carl V; Lachmann PJ
    J Immunol; 1989 Jun; 142(12):4366-71. PubMed ID: 2524529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
    Craig ML; Waitumbi JN; Taylor RP
    J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Difference in the clustering of complement receptor type 1 (CR1) on polymorphonuclear leukocytes and erythrocytes: effect on immune adherence.
    Paccaud JP; Carpentier JL; Schifferli JA
    Eur J Immunol; 1990 Feb; 20(2):283-9. PubMed ID: 2138082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the mechanisms responsible for the reduction in erythrocyte complement receptors when immune complexes form in vivo in primates.
    Cosio FG; Shen XP; Birmingham DJ; Van Aman M; Hebert LA
    J Immunol; 1990 Dec; 145(12):4198-206. PubMed ID: 2147938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.
    Java A; Liszewski MK; Hourcade DE; Zhang F; Atkinson JP
    Mol Immunol; 2015 Oct; 67(2 Pt B):584-95. PubMed ID: 26260209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of processing by erythrocyte C3b/C4b receptors (CR1) on binding of immune complexes to Raji cells and polymorphonuclear granulocytes.
    Rasmussen JM; Jepsen HH; Svehag SE
    Scand J Immunol; 1987 Oct; 26(4):437-44. PubMed ID: 2961050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune complex binding to erythrocyte-CR1 (CD 35), CR1 expression and levels of erythrocyte-fixed C3 fragments in SLE outpatients.
    Jepsen HH; Møller Rasmussen J; Teisner B; Schrøder L; Holmskov U; Jarlbaek L; Isager H; Svehag SE
    APMIS; 1990 Jul; 98(7):637-44. PubMed ID: 2144431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and functional analysis of recombinant scFv and diabody fragments with specificity for human RhD.
    Asvadi P; Fletcher A; Raison RL
    J Mol Recognit; 2002; 15(5):321-30. PubMed ID: 12447910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.
    Yoon SH; Fearon DT
    J Immunol; 1985 May; 134(5):3332-8. PubMed ID: 3156931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of complement-solubilized immune complexes with CR1 receptors on human erythrocytes. The binding reaction.
    Jepsen HH; Svehag SE; Jarlbaek L; Baatrup G
    Scand J Immunol; 1986 Jan; 23(1):65-73. PubMed ID: 2939551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of CR1 complement receptor in pathology].
    Rochowiak A; Niemir ZI
    Pol Merkur Lekarski; 2010 Jan; 28(163):84-8. PubMed ID: 20369733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement receptor is an inhibitor of the complement cascade.
    Iida K; Nussenzweig V
    J Exp Med; 1981 May; 153(5):1138-50. PubMed ID: 6910481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune complex clearance by complement receptor type 1 in SLE.
    Kavai M
    Autoimmun Rev; 2008 Dec; 8(2):160-4. PubMed ID: 18602499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The roles of complement receptors type 1 (CR1, CD35) and type 3 (CR3, CD11b/CD18) in the regulation of the immune complex-elicited respiratory burst of polymorphonuclear leukocytes in whole blood.
    Nielsen CH; Antonsen S; Matthiesen SH; Leslie RG
    Eur J Immunol; 1997 Nov; 27(11):2914-9. PubMed ID: 9394818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Another function of erythrocytes: transport of circulating immune complexes.
    Pascual M; Schifferli JA
    Infusionsther Transfusionsmed; 1995 Oct; 22(5):310-5. PubMed ID: 8924746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of complement receptor type 1 (CR1) on erythrocytes of paracoccidiodomycosis patients.
    Teixeira JE; Martinez R; Câmara LM; Barbosa JE
    Mycopathologia; 2001; 152(3):125-33. PubMed ID: 11811640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE).
    Cohen JH; Lutz HU; Pennaforte JL; Bouchard A; Kazatchkine MD
    Clin Exp Immunol; 1992 Mar; 87(3):422-8. PubMed ID: 1531948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases.
    Miyaike J; Iwasaki Y; Takahashi A; Shimomura H; Taniguchi H; Koide N; Matsuura K; Ogura T; Tobe K; Tsuji T
    Gut; 2002 Oct; 51(4):591-6. PubMed ID: 12235086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.